Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men

被引:0
|
作者
Kahn, SE [1 ]
Leonetti, DL [1 ]
Prigeon, RL [1 ]
Boyko, EJ [1 ]
Bergstom, RW [1 ]
Fujimoto, WY [1 ]
机构
[1] UNIV WASHINGTON,DIV METAB,SEATTLE,WA 98195
关键词
impaired glucose tolerance; C-peptide; glucose; obesity; beta-cell; insulin resistance; intra-abdominal fat;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disproportionate hyperproinsulinaemia is a manifestation of the beta-cell dysfunction observed in NIDDM. However, it is unclear when this abnormality develops and whether it predicts the development of the disease. To examine whether changes in proinsulin levels predict the development of NIDDM, baseline measurements of proinsulin and immunoreactive insulin levels were made in 87 second-generation Japanese-American men, a population at high risk for the subsequent development of NIDDM. Subjects were categorized at baseline using WHO criteria as having normal glucose tolerance (NGT; n = 49) or impaired glucose tolerance (IGT; n = 38). After a 5-year follow-up period, subjects were recategorized as having NGT, IGT or NIDDM using the same criteria. During follow-up, 16 subjects developed NIDDM while 71 were NGT or IGT. At baseline, individuals who subsequently developed NIDDM were more obese as measured by intra-abdominal fat area on computed tomography (p = 0.046), had higher fasting glucose (p = 0.0042), 2-h glucose (p = 0.0002), fasting C-peptide (p = 0.0011), fasting proinsulin levels (p = 0.0033), and had disproportionate hyperproinsulinaemia (p = 0.056) when compared to those who remained NGT or IGT after 5 years of follow-up. These findings suggest that alterations in proinsulin levels may also predict the subsequent development of NIDDM.
引用
收藏
页码:S63 / S66
页数:4
相关论文
共 50 条
  • [41] RHUS CORIARIA AMELIORATES INSULIN RESISTANCE IN NON-INSULIN-DEPENDENT DIABETES MELLITUS (NIDDM) RATS
    Anwer, Tarique
    Sharma, Manju
    Khan, Gyas
    Iqbal, Muzaffar
    Ali, Mohammad Sajid
    Alam, Mohammad Sarfaraz
    Safhi, Mohammed Mohsen
    Gupta, Nakul
    ACTA POLONIAE PHARMACEUTICA, 2013, 70 (05): : 861 - 867
  • [42] ELEVATED PLASMA-LEVELS OF PANCREASTATIN (PST) IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
    FUNAKOSHI, A
    TATEISHI, K
    SHINOZAKI, H
    MATSUMOTO, M
    WAKASUGI, H
    REGULATORY PEPTIDES, 1990, 30 (02) : 159 - 164
  • [43] LOWER ENDOGENOUS ANDROGEN LEVELS AND DYSLIPIDEMIA IN MEN WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    BARRETTCONNOR, E
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (10) : 807 - 811
  • [44] PANCREATIC PATHOLOGY IN NON-INSULIN-DEPENDENT DIABETES (NIDDM)
    CLARK, A
    DEKONING, EJP
    HATTERSLEY, AT
    HANSEN, BC
    YAJNIK, CS
    POULTON, J
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 : S39 - S47
  • [45] A SURVEY OF ACTIVITY LEVELS AND ATTITUDES TOWARDS EXERCISE IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
    RODNICK, KJ
    HASKELL, WL
    REAVEN, GM
    CLINICAL RESEARCH, 1989, 37 (01): : A117 - A117
  • [46] MECHANISMS OF ACTION OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
    PEDERSEN, O
    NIELSEN, OH
    SCHMITZ, O
    BECKNIELSEN, H
    BAK, J
    ANDERSEN, PH
    SORENSEN, NS
    ACTA ENDOCRINOLOGICA, 1987, 115 : 47 - 47
  • [47] DESIGN OF NOVEL AGENTS FOR THE THERAPY OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
    BELL, P
    CHEON, SH
    FILLERS, S
    FOLEY, J
    FRASER, J
    SMITH, H
    YOUNG, D
    REVESZ, L
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (06) : 1007 - 1012
  • [48] LOVASTATIN THERAPY FOR CHOLESTEROL LOWERING IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
    GARG, A
    GRUNDY, SM
    CLINICAL RESEARCH, 1987, 35 (03): : A503 - A503
  • [49] Dietary protein in non-insulin-dependent diabetes mellitus (NIDDM): Effect on renal function
    Chattington, P
    Moran, J
    Vora, IJJ
    DIABETES, 1998, 47 : A373 - A373
  • [50] Plasma homocysteine concentrations as predictor of mortality in non-insulin-dependent (NIDDM) diabetes mellitus
    Gall, MA
    Stehouwer, CDA
    Hougaard, P
    Jakobs, C
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0562 - A0562